欢迎访问西域试剂网!

请登录 | 免费注册

Ningetinib 宁格替尼,99.79%

产品编号:Bellancom-107145A| CAS NO:1394820-69-9| 分子式:C31H29FN4O5| 分子量:556.58

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-107145A
850.00 杭州 北京(现货)
Bellancom-107145A
1200.00 杭州 北京(现货)
Bellancom-107145A
2500.00 杭州 北京(现货)
Bellancom-107145A
4200.00 杭州 北京(现货)
Bellancom-107145A
7200.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

Ningetinib 宁格替尼

产品介绍 Ningetinib 是一种有效的口服生物可用的小分子酪氨酸激酶抑制剂 (TKI),对 c-MetVEGFR2AxlIC50 值分别为 6.7, 1.9 和 <1.0 nM。
生物活性

Ningetinib is a potent, orally bioavailable small molecule tyrosine kinase inhibitor (TKI) with IC50s of 6.7, 1.9 and <1.0 nM for c-Met, VEGFR2 and Axl, respectively.

体外研究

Ningetinib is a potent, orally bioavailable small molecule tyrosine kinase inhibitor (TKI) with IC50s of 6.7, 1.9 and <1.0 nM for c-Met, VEGFR2 and Axl, respectively. In cell-based functional assays, Ningetinib (CT053PTSA) inhibits HGF and VEGF-stimulated HUVEC proliferation and microvascular angiogenesis in rat aortic rings with IC50 values of 8.6 and 6.3 nM, respectively.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

When single dosed orally (3 mg/kg) to U87MG tumor-bearing nude mice, Ningetinib (CT053PTSA) potently inhibits the phosphorylation of c-Met and its downstream signaling kinases AKT and ERK1/2 for up to 6 hours in tumor tissues. In orthotopic U87MG human glioblastoma xenograft model, Ningetinib prolongs the median survival time (MST) and yields significant increase in life-span value (ILS=32%, p=0.003) at an oral dose of 20 mg/kg/day (dosed 21 days) versus the vehicle-treated group.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

When single dosed orally (3 mg/kg) to U87MG tumor-bearing nude mice, Ningetinib (CT053PTSA) potently inhibits the phosphorylation of c-Met and its downstream signaling kinases AKT and ERK1/2 for up to 6 hours in tumor tissues. In orthotopic U87MG human glioblastoma xenograft model, Ningetinib prolongs the median survival time (MST) and yields significant increase in life-span value (ILS=32%, p=0.003) at an oral dose of 20 mg/kg/day (dosed 21 days) versus the vehicle-treated group.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

性状Solid
溶解性数据
In Vitro: 

DMSO : 16.67 mg/mL (29.95 mM; Need ultrasonic)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 1.7967 mL 8.9834 mL 17.9669 mL
5 mM 0.3593 mL 1.7967 mL 3.5934 mL
10 mM 0.1797 mL 0.8983 mL 1.7967 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


服务热线

13911702513
18601927057

微信客服